The peptide's effects on circadian regulation and sleep may provide particular benefit during perimenopause when these systems become disrupted
The currently approved GLP-1 RAs include exenatide, liraglutide, lixisenatide, dulaglutide, and semaglutide 3
The medication's appetite-suppressing effects fade, and you may notice increased hunger and food cravings returning to pre-treatment levels or potentially higher
More receptors activated does not automatically mean better for every person

Seek same-day medical advice if you experience: Sudden, severe pain in a joint, particularly the big toe, ankle, or knee, often developing overnight Visible swelling, redness, and warmth over the affected joint Extreme tenderness making it difficult to bear weight or tolerate even light touch (such as bedsheets) Fever or feeling generally unwell accompanying joint symptoms, which may indicate infection (septic arthritis) requiring urgent assessment (contact NHS 111, an urgent treatment centre, or A&E) Contact your GP promptly if: You have a known history of gout and experience symptoms suggestive of a flare-up Joint symptoms are moderate but persistent and affecting daily activities You have recurrent episodes of joint pain since starting Ozempic You are uncertain whether symptoms represent gout or another condition Arrange a routine appointment to discuss: Preventive strategies if you have a history of gout before starting Ozempic Uric acid monitoring if you are at higher risk (family history, previous gout, kidney disease) Medication adjustments if you experience frequent flare-ups despite preventive measures It is important to note that acute gout attacks should not necessarily lead to discontinuation of Ozempic

Route Intravenous Amount per session 250-500 mg